title: The role of somatostatin analogs in the management of medullary thyroid carcinoma.
authors.affiliation: Department of Molecular and Clinical Oncology and Endocrinology, Federico II University, Naples, Italy. lupoli@unina.it
authors.forename: G A
authors.initials: GA
authors.lastname: Lupoli
authors.forename: F
authors.initials: F
authors.lastname: Fonderico
authors.forename: M R
authors.initials: MR
authors.lastname: Fittipaldi
authors.forename: S
authors.initials: S
authors.lastname: Colarusso
authors.forename: A
authors.initials: A
authors.lastname: Panico
authors.forename: A
authors.initials: A
authors.lastname: Cavallo
authors.forename: L
authors.initials: L
authors.lastname: Di Micco
authors.forename: G
authors.initials: G
authors.lastname: Lupoli
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018276:Carcinoma, Medullary / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D016898:Interferon-alpha / Q000008:administration & dosage; D015282:Octreotide / Q000008:administration & dosage; D010456:Peptides, Cyclic / Q000008:administration & dosage; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013964:Thyroid Neoplasms / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007155:Immunologic Factors; D016898:Interferon-alpha; D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin; D015282:Octreotide